Headquarters
760 PARKSIDE AVE, BROOKLYN, NY 11226-1508, US
BROOKLYN, NY, US
CONCARLO THERAPEUTICS INC
From the company
Concarlo Therapeutics is a biotech company developing novel therapeutics to improve outcomes for cancer patients, using innovation in p27 biology. It is described as the first company to target CDK4/6-driven cell proliferation and CDK2-driven resistance. Its mission is to improve outcomes for patients with drug-resistant cancers by creating transformative therapies that control the p27 target.
Products & services offered
Capabilities 5
Classifications
- Ownership classifications (2)
- Woman Owned Business, Woman Owned Small Business
Facilities
Send your requirements
Quantities, certifications, and timing.